Cargando…

Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin

BACKGROUND: People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Dheda, Shyam, Vesey, David A, Hawley, Carmel, Johnson, David W, Fahim, Magid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930269/
https://www.ncbi.nlm.nih.gov/pubmed/35310812
http://dx.doi.org/10.1155/2022/8632245
_version_ 1784671026586583040
author Dheda, Shyam
Vesey, David A
Hawley, Carmel
Johnson, David W
Fahim, Magid
author_facet Dheda, Shyam
Vesey, David A
Hawley, Carmel
Johnson, David W
Fahim, Magid
author_sort Dheda, Shyam
collection PubMed
description BACKGROUND: People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The origin of this inflammation remains elusive and one putative cause is elevated levels of circulating bacterial endotoxin. METHODS: In this study, serum concentrations of endotoxin and inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), interleukin-1β (IL1β), ferritin and tumor necrosis factor (TNF), were measured in 30 adults receiving HD and 10 healthy individuals without kidney disease. In people receiving HD, samples were collected immediately before dialysis (preHD), after dialysis (postHD), and 48 hours after (postHD(48hrs)). RESULTS: Endotoxin was detectable in only 1 of 90 samples analyzed. There were no significant differences in serum hsCRP, IL1β, and IL6 levels, before and after dialysis. Serum TNF levels decreased significantly from 30.9 (8.0, 39.5) pg/mL preHD to 13.9 (8.5, 17.3) pg/mL post-HD (p=0.002) and then increased back to 27.37 (14.5, 35) pg/mL 2 days later (p < 0.001). Ferritin increased from 1153 ng/mL (782, 1458) preHD to 1313 ng/mL (657, 1638) post HD (p < 0.001) and then decreased back to 1186 ng/mL (754, 1597) (p=0.66) postHD(48hrs.) Compared to controls, people receiving HD had significantly elevated levels of hsCRP [6.16 mg/L (2.1, 16.8) vs. 1.1 mg/L (0.81, 3.63) p=0.015], IL1β [1.5 pg/mL (0.05, 2.51) vs. 0.5 pg/mL (1.81, 2.95) p ≤ 0.001], and ferritin [1153 (782, 1458) vs. 132.9 (111, 257) ng/mL p ≤ 0.001], but comparable levels of in IL6 [6.15 pg/mL (4.82, 9.12) vs. 7.49 pg/mL (4.56, 10.39), p=0.77] and TNF [27.35 pg/mL ± 17.48 vs. 17.87 pg/mL ± 12.28, p < 0.12]. In conclusion, people on HD have elevated levels of inflammatory biomarkers, which are not associated with endotoxemia (which is rare) or the dialysis procedure.
format Online
Article
Text
id pubmed-8930269
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89302692022-03-18 Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin Dheda, Shyam Vesey, David A Hawley, Carmel Johnson, David W Fahim, Magid Int J Inflam Research Article BACKGROUND: People receiving hemodialysis (HD) treatment have higher cardiovascular morbidity and mortality, ascribed to an increased prevalence of traditional cardiovascular risk factors. However, the role of nontraditional risk factors, such as inflammation, has become increasingly recognized. The origin of this inflammation remains elusive and one putative cause is elevated levels of circulating bacterial endotoxin. METHODS: In this study, serum concentrations of endotoxin and inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), interleukin-1β (IL1β), ferritin and tumor necrosis factor (TNF), were measured in 30 adults receiving HD and 10 healthy individuals without kidney disease. In people receiving HD, samples were collected immediately before dialysis (preHD), after dialysis (postHD), and 48 hours after (postHD(48hrs)). RESULTS: Endotoxin was detectable in only 1 of 90 samples analyzed. There were no significant differences in serum hsCRP, IL1β, and IL6 levels, before and after dialysis. Serum TNF levels decreased significantly from 30.9 (8.0, 39.5) pg/mL preHD to 13.9 (8.5, 17.3) pg/mL post-HD (p=0.002) and then increased back to 27.37 (14.5, 35) pg/mL 2 days later (p < 0.001). Ferritin increased from 1153 ng/mL (782, 1458) preHD to 1313 ng/mL (657, 1638) post HD (p < 0.001) and then decreased back to 1186 ng/mL (754, 1597) (p=0.66) postHD(48hrs.) Compared to controls, people receiving HD had significantly elevated levels of hsCRP [6.16 mg/L (2.1, 16.8) vs. 1.1 mg/L (0.81, 3.63) p=0.015], IL1β [1.5 pg/mL (0.05, 2.51) vs. 0.5 pg/mL (1.81, 2.95) p ≤ 0.001], and ferritin [1153 (782, 1458) vs. 132.9 (111, 257) ng/mL p ≤ 0.001], but comparable levels of in IL6 [6.15 pg/mL (4.82, 9.12) vs. 7.49 pg/mL (4.56, 10.39), p=0.77] and TNF [27.35 pg/mL ± 17.48 vs. 17.87 pg/mL ± 12.28, p < 0.12]. In conclusion, people on HD have elevated levels of inflammatory biomarkers, which are not associated with endotoxemia (which is rare) or the dialysis procedure. Hindawi 2022-03-10 /pmc/articles/PMC8930269/ /pubmed/35310812 http://dx.doi.org/10.1155/2022/8632245 Text en Copyright © 2022 Shyam Dheda et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dheda, Shyam
Vesey, David A
Hawley, Carmel
Johnson, David W
Fahim, Magid
Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_full Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_fullStr Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_full_unstemmed Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_short Effect of a Hemodialysis Session on Markers of Inflammation and Endotoxin
title_sort effect of a hemodialysis session on markers of inflammation and endotoxin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930269/
https://www.ncbi.nlm.nih.gov/pubmed/35310812
http://dx.doi.org/10.1155/2022/8632245
work_keys_str_mv AT dhedashyam effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT veseydavida effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT hawleycarmel effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT johnsondavidw effectofahemodialysissessiononmarkersofinflammationandendotoxin
AT fahimmagid effectofahemodialysissessiononmarkersofinflammationandendotoxin